342 The tri-agonist lowered body weight in diet-induced obese mice by 26.6% after 20 days of treatment, whereas the GLP-1R/GIPR coagonist lowered body weight by 15.7%, and it was found that the action of the tri-agonist occurred in a dose-dependent manner
Researchers in 2026 should evaluate both compounds against current Phase 3 data as it becomes available
The key takeaway is that preparation matters
These maintain refrigerator temperatures indefinitely while the car is running
During treatment with GLP-1 based medications, regular follow-up appointments allow your healthcare provider to monitor progress, adjust doses as needed, and identify any concerning side effects early
5 mg Vials (TB500, 5 mg each) 8 weeks 8 vials 12 weeks 12 vials 16 weeks 16 vials 10 mg Vials (TB500, 10 mg each) 8 weeks 4 vials 12 weeks 7 vials 16 weeks 10 vials Insulin Syringes (U100) Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles) Use ~3.0 mL per vial for reconstitution
